Net profit of ERIS Lifesciences rose 19.05% to Rs 99.72 crore in the quarter ended December 2025 as against Rs 83.76 crore during the previous quarter ended December 2024. Sales rose 10.91% to Rs 800.89 crore in the quarter ended December 2025 as against Rs 722.12 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended |
| Dec. 2025 | Dec. 2024 | % Var. |
| Sales | 800.89 | 722.12 | 11 |
| OPM % | 35.16 | 34.66 | - |
| PBDT | 232.93 | 197.36 | 18 |
| PBT | 162.59 | 116.36 | 40 |
| NP | 99.72 | 83.76 | 19 |